Nancy Davenport-Ellis, a breast cancer survivor and founder of the Patient Advocate Foundation, discusses the expense of cancer care for patients and the complexities of health insurance, Medicare, and Medicaid.
Jeff Goad and his wife, Ramona Biliunas, discuss why the climbed Mount Kilimanjaro as part of the Moving Mountains for Multiple Myeloma team. Jeff was also one of our 2016 Multiple Myeloma Heroes.
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
Finn says it's important for advocacy organizations to attend and socialize at these conferences to explore possible collaborations.
Why is November not named an "awareness month?" Because stomach cancer isn't only about awareness.
Typically, the longer a patient with cancer is exposed to a drug the more side effects they experience, but in the case of Imbruvica, the opposite appears to be true for patients with MCL.
There is no right way to celebrate (or not celebrate) a cancerversary.
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2020 Young Investigator Awards (YIA), to support the development of outstanding early-career research scientists and clinical cancer research investigators.
An Extraordinary Healer essay honoring Claudia Davis, RN, OCN, CBCN [Community North, Community Health Network in Indianapolis, Indiana]
Soup, cider and salmon help keep the body full and fueled when it’s frigid outdoors.
Preliminary results of two new targeted therapies, now in late-stage clinical trials, hold much promise for men with hormone-refractory, or castration-resistant, prostate cancer.
An Extraordinary Healer essay honoring KAITLYN WHITEWATER, B.S.N., RN [SAINT FRANCIS HOSPITAL, 7 WEST ONCOLOGY/BONE MARROW TRANSPLANT UNIT, TULSA, OKLAHOMA]
FOR 19 YEARS, Anne Todd served as a secretary in an oncology office where the doctor enjoyed teaching her about the disease.
When Joanne Lam was diagnosed with bladder cancer, her husband showed unwavering devotion in caring for her. Now it's her turn to be his caregiver.
Low-grade gliomas may be classified into three distinct prognostic categories based on genomic data.
Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.
Patients with lung cancer are encouraged to participate in the new modules that will capture data to help gain insights into their treatment path and treatment options.
Practitioners see benefits of tai chi after cancer, while researchers have only begun to look.
This essay was written by Dr. Kevin Yiee, CHI Health St. Elizabeth, nominating registered oncology-certified nurse Robin Devries for CURE®’s 2019 Extraordinary Healer® Award.
I WOULD LIKE TO NOMINATE one of our current nurses, the extraordinary Ann E. Grotz, a registered nurse at Compass Oncology, for this year's award.
When one woman experienced symptoms of chronic lymphocytic leukemia, people blamed her nerves and told her to rest. Instead, she listened to her body.
Mark Heaney, M.D., Ph.D., Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, discusses the pros and cons of patients with myeloproliferative neoplasms (MPNs) researching their diagnosis online.
In this nomination essay for the CURE® Extraordinary Healer® Award, Cora Beth Hartfield honors finalist Angela Hammack, B.S.N., RN, OCN.
Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Sidney Kimmel Cancer Center, discusses plans to maintain momentum on the Cancer Moonshot initiative.
Susan Melvin Hill, patient advocate, tells her MPN story and discusses how she helps patients with myeloproliferative neoplasms (MPNs) in Idaho.